ZHU; Shigui

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZHU; Shigui.The latest application filed is for "combined chimeric antigen receptor targeting cd19 and cd20 and application thereof".

Company Profile

1.6.9

ZHU; Shigui - Rockville MD
Zhu; Shigui - Hong Kong CN
Zhu; Shigui - Shanghai CN

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof App 20220288123 - YAO; Yihong ; et al.	2022-09-15
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof Grant 11,439,665 - Yao , et al. September 13, 2	2022-09-13
Construction Of Chimeric Antigen Receptor Targeting Cd20 Antigen And Activity Identification Of Engineered T Cells Thereof App 20220281945 - YAO; Yihong ; et al.	2022-09-08
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof App 20220249568 - YAO; Yihong ; et al.	2022-08-11
Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof Grant 11,339,200 - Yao , et al. May 24, 2	2022-05-24
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof Grant 11,331,347 - Yao , et al. May 17, 2	2022-05-17
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof App 20220031752 - YAO; Yihong ; et al.	2022-02-03
BCMA-Targeted Chimeric Antigen Receptor as well as Preparation Method Therefor and Application Thereof App 20210403590 - WEI; Yutian ; et al.	2021-12-30
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof Grant 11,207,349 - Yao , et al. December 28, 2	2021-12-28
Construction Of Chimeric Antigen Receptor Targeting Cd20 Antigen And Activity Identification Of Engineered T Cells Thereof App 20210361710 - YAO; Yihong ; et al.	2021-11-25
BCMA-targeted chimeric antigen receptor as well as preparation method therefor and application thereof Grant 11,142,581 - Wei , et al. October 12, 2	2021-10-12
Combined chimeric antigen receptor targeting CD19 and CD20 and application thereof App 20210290673 - YAO; Yihong ; et al.	2021-09-23
Construction of chimeric antigen receptor targeting CD20 antigen and activity identification of engineered T cells thereof Grant 11,066,457 - Yao , et al. July 20, 2	2021-07-20
Bcma-targeted Chimeric Antigen Receptor As Well As Preparation Method Therefor And Application Thereof App 20200362048 - WEI; Yutian ; et al.	2020-11-19
Construction Of Chimeric Antigen Receptor Targeting Cd20 Antigen And Activity Identification Of Engineered T Cells Thereof App 20200002400 - YAO; Yihong ; et al.	2020-01-02

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.